PROSTATE CANCER Localized disease-are most men really suitable for focal therapy?

Ben Challacombe; Luke Dixon

doi:10.1038/nrurol.2013.297

PROSTATE CANCER Localized disease-are most men really suitable for focal therapy?

Ben Challacombe^*, Luke Dixon

^*Corresponding author for this work

GSTT Guy's and St Thomas' NHS Foundation Trust

Research output: Contribution to journal › Editorial › peer-review

1 Citation (Scopus)

Abstract

In the quest for reduced morbidity from radical treatments, tissue-sparing focal therapies are being developed to treat men with localized prostate cancer. However, which patients are most suitable for these experimental therapies remains unclear. One population-based study suggests that the majority of patients are suitable candidates.

Original language	English
Pages (from-to)	7-8
Number of pages	2
Journal	Nature Reviews Urology
Volume	11
Issue number	1
DOIs	https://doi.org/10.1038/nrurol.2013.297
Publication status	Published - Jan 2014

Keywords

SPECIMENS
ORIGIN

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/nrurol.2013.297

Cite this

@article{1af5a08e86474b57879bb336078a3992,

title = "PROSTATE CANCER Localized disease-are most men really suitable for focal therapy?",

abstract = "In the quest for reduced morbidity from radical treatments, tissue-sparing focal therapies are being developed to treat men with localized prostate cancer. However, which patients are most suitable for these experimental therapies remains unclear. One population-based study suggests that the majority of patients are suitable candidates.",

keywords = "SPECIMENS, ORIGIN",

author = "Ben Challacombe and Luke Dixon",

year = "2014",

month = jan,

doi = "10.1038/nrurol.2013.297",

language = "English",

volume = "11",

pages = "7--8",

journal = "Nature Reviews Urology",

issn = "1759-4812",